Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elisabetta Squame
Observed names:
E. Squame,
Squame Elisabetta,
Squame, Elisabetta
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0000-0002-3871-6069
Observed ORCID:
0000-0002-3871-6069
OpenAlex ID:
A5045699234
Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
2022
·
Costantina Maisto
, Michela Aurilio
, et al.
·
Molecules
·
29
PDF
On site production of [18F]PSMA-1007 using different [18F]fluoride activities: practical, technical and economical impact
2021
·
Costantina Maisto
, Anna Morisco
, et al.
·
EJNMMI Radiopharmacy and Chemistry
·
17
PDF
Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma
2007
·
Filippo Russo
, Secondo Lastoria
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
15
[177Lu] Lu-PSMA-I&T for prostate cancer radioligand therapy: A radiopharmacy’s journey from synthesis to cost-effectiveness
2026
·
Michela Aurilio
, Costantina Maisto
, et al.
·
Applied Radiation and Isotopes
Dosimetric comparison between 177LU-PSMA-617 and 177LU-PSMA I&T in patients with metastatic castration resistant prostate cancer (MCRPC) using a ring-shaped CZT-based camera
2026
·
L. D’Ambrosio
, F. Manna
, et al.
·
Physica Medica
RETRACTED: [177Lu] Lu-PSMA-I&T for Prostate Cancer Radioligand Therapy: A Radiopharmacy's Journey from Synthesis to Cost-Effectiveness
2025
·
Michela Aurilio
, Costantina Maisto
, et al.
·
Research Square
Analysis of Pros and Cons in using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: production, costs and PET/CT applications in patients with Prostate Cancer.
2022
·
Maisto Costantina
, Aurilio Michela
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Early PET-CT evaluation of patients with metastatic colorectal cancer undergoing treatment with an experimental bevacizumab schedule in combination with standard chemotherapy regimens
2013
·
Luigi Aloj
, Antonio Avallone
, et al.
·
Journal of Nuclear Medicine
Show more works
View as search
Works count:
9
Citation count:
61
H-index:
3
I10-index:
3
Year
Topic
Type